Processa Pharmaceuticals, Inc. (PCSA)
2.05
-0.11
(-5.09%)
USD |
NASDAQ |
Sep 09, 09:57
Processa Pharmaceuticals Market Cap : 5.726M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 6.034M |
| September 04, 2026 | 5.754M |
| September 03, 2026 | 5.726M |
| September 02, 2026 | 5.866M |
| September 01, 2026 | 5.726M |
| August 31, 2026 | 5.726M |
| August 28, 2026 | 5.754M |
| August 27, 2026 | 5.894M |
| August 26, 2026 | 5.950M |
| August 25, 2026 | 6.090M |
| August 24, 2026 | 6.062M |
| August 21, 2026 | 5.810M |
| August 20, 2026 | 5.992M |
| August 19, 2026 | 6.006M |
| August 18, 2026 | 5.866M |
| August 17, 2026 | 5.950M |
| August 14, 2026 | 6.788M |
| August 13, 2026 | 6.984M |
| August 12, 2026 | 7.151M |
| August 11, 2026 | 7.043M |
| August 10, 2026 | 6.989M |
| August 07, 2026 | 6.882M |
| August 06, 2026 | 6.159M |
| August 05, 2026 | 5.864M |
| August 04, 2026 | 5.677M |
| Date | Value |
|---|---|
| August 03, 2026 | 5.704M |
| July 31, 2026 | 5.757M |
| July 30, 2026 | 5.463M |
| July 29, 2026 | 5.436M |
| July 28, 2026 | 8.167M |
| July 27, 2026 | 6.936M |
| July 24, 2026 | 6.962M |
| July 23, 2026 | 7.685M |
| July 22, 2026 | 6.802M |
| July 21, 2026 | 5.998M |
| July 20, 2026 | 5.945M |
| July 17, 2026 | 6.186M |
| July 16, 2026 | 5.998M |
| July 15, 2026 | 6.400M |
| July 14, 2026 | 6.132M |
| July 13, 2026 | 5.516M |
| July 10, 2026 | 5.784M |
| July 09, 2026 | 5.275M |
| July 08, 2026 | 5.061M |
| July 07, 2026 | 5.061M |
| July 06, 2026 | 5.623M |
| July 02, 2026 | 5.784M |
| July 01, 2026 | 5.248M |
| June 30, 2026 | 5.141M |
| June 29, 2026 | 5.195M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.612B |
| Corcept Therapeutics, Inc. | 12.56B |
| Veru, Inc. | 43.65M |
| Johnson & Johnson | 649.45B |
| Eli Lilly & Co. | 1.071T |
Market Cap Related Metrics
| Price | 2.05 |
| Earnings Yield | -272.6% |